Immune Checkpoint Inhibitors to Treat Malignant Lymphomas.

about

Immune Checkpoint Inhibitors to Treat Malignant Lymphomas.

Item

http://www.wikidata.org/entity/Q55106038

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Immune Checkpoint Inhibitors to Treat Malignant Lymphomas.

@en

Immune Checkpoint Inhibitors to Treat Malignant Lymphomas.

@nl

type

Item

label

Immune Checkpoint Inhibitors to Treat Malignant Lymphomas.

@en

Immune Checkpoint Inhibitors to Treat Malignant Lymphomas.

@nl

prefLabel

Immune Checkpoint Inhibitors to Treat Malignant Lymphomas.

@en

Immune Checkpoint Inhibitors to Treat Malignant Lymphomas.

@nl

P1476

Immune Checkpoint Inhibitors to Treat Malignant Lymphomas

@en

P2093

Magdalena Witkowska

http://www.w3.org/2001/XMLSchema#string

Piotr Smolewski

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

LAG-3, a novel lymphocyte activation gene closely related to CD4

Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.

Cancer statistics, 2013

The blockade of immune checkpoints in cancer immunotherapy

A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

Cutting edge: molecular analysis of the negative regulatory function of lymphocyte activation gene-3

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphoma.

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.

P304

1982423

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/1982423

http://www.w3.org/2001/XMLSchema#string

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Magdalena Witkowska

Piotr Smolewski

P5008

ScienceSource

P577

2018-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29850620

http://www.w3.org/2001/XMLSchema#string

P921

lymphoma

cell surface receptor

hemic and immune systems

Achyolli

P932

5925139

http://www.w3.org/2001/XMLSchema#string